Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer-Reference-Cited by-同舟云学术

Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer

Published:2008-12 Issue:6 Volume:248 Page:902-908
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Schneider Paul M.,Metzger Ralf,Schaefer Hartmut,Baumgarten Frank,Vallbohmer Daniel,Brabender Jan,Wolfgarten Eva,Bollschweiler Elfriede,Baldus Stephan E.,Dienes Hans P.,Hoelscher Arnulf H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference34 articles.

1. Epidemiology of esophageal adenocarcinoma.;Pera;J Surg Oncol,2005

2. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.;Lerut;Curr Opin Gastroenterol,2006

3. Multimodality therapy for esophageal cancer.;Refaely;Surg Clin North Am,2002

4. Locally advanced esophageal cancer.;Sherman;Curr Treat Options Oncol,2002

5. En-bloc esophagectomy–the three-field dissection.;Altorki;Surg Clin North Am,2005

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of imaging methods for prognosis assessment in esophageal squamous cell carcinoma: focus on diffusion-weighted magnetic resonance imaging, computed tomography and esophagography;Frontiers in Oncology;2024-07-03

2. CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients;Journal of Translational Medicine;2024-06-18

3. Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study;Molecular and Clinical Oncology;2024-02-09

4. A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades;Cancers;2023-08-14

5. Survival Outcomes of Patients with Esophageal Cancer Who Did Not Proceed to Surgery after Neoadjuvant Treatment;Cancers;2023-08-10